Home › Kanser sa Balat › New Jersey
Pag-aaral pangklinika para sa Kanser sa Balat sa New Jersey
6 pag-aaral para sa Kanser sa Balat ang naghahanap ng mga kalahok sa mga site sa New Jersey.
Mga Lungsod sa New Jersey
Opisyal na teksto ng pag-aaral (English)
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- MD Anderson Cancer Center at Cooper, Camden
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT05727904A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05859074Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
- Hackensack University Medical Center, Hackensack
- Atlantic Health System, Morristown
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06947928A Mobile Health Intervention Among Hispanics
- Rutgers Cancer Institute of New Jersey, New Brunswick
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Dis 16, 2025 · NCT05389332SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Naltrexone and Propranolol Combined With Immunotherapy
- Rutgers Cancer Institute of New Jersey, New Brunswick
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2025 · NCT05968690Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.